CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 265 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,369,326 | -8.9% | 282,074 | -6.3% | 0.85% | +4.4% |
| Q1 2024 | $4,797,159 | -7.3% | 300,951 | -2.3% | 0.82% | -12.4% |
| Q4 2023 | $5,176,001 | +61.9% | 307,912 | +12.6% | 0.93% | +53.6% |
| Q3 2023 | $3,197,355 | -9.4% | 273,512 | +4.2% | 0.61% | -11.5% |
| Q2 2023 | $3,527,153 | +5.3% | 262,437 | +29.9% | 0.68% | +1.3% |
| Q1 2023 | $3,350,520 | – | 202,082 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |